French Market Authority (Autorité des Marchés Financiers - AMF) announced today the implementation of a squeeze-out on NATUREX remaining shares not tendered to the offer initiated by GIVAUDAN on NATUREX shares.
Indeed, as announced on September 7th after the reopening of the offer, GIVAUDAN now holds 9,436,645 NATUREX shares, representing 98.06% of the capital.
The squeeze-out procedure concerns 182,374 NATUREX shares not presented to the offer by the minority shareholders, ie 1.90% of the share capital.
The squeeze-out will take place on 18th September 2018 at a price of € 135 per share, which is the same price as the public takeover bid and will be followed by a delisting from Euronext Paris.
The detailed schedule for the implementation of the squeeze-out and the delisting date will be published by Euronext Paris.
It is specified that the suspension of the listing of NATUREX shares is maintained until the implementation of the squeeze-out.
For more information, visit the dedicated website: www.opa-naturex.com.
- Contacts investors and media
|Carole Alexandre |
Head of Investor Relations
Tel.: +33 (0)4 90 23 78 28
|Anne Catherine Bonjour |
Actus finance & communication - Press Relations
Tel.: +33 (0)1 53 67 36 93
Naturex sources, manufactures and markets natural speciality ingredients for the food, health and cosmetic industries. As the Natural Maker, the company actively supports the global shift from synthetic to natural through an offer built on two main focus areas: My Natural Food and My Natural Selfcare. Naturex's portfolio includes colours, antioxidants, speciality fruits & vegetables, phytoactives, and numerous other plant-based natural ingredients, designed to create healthy, authentic and effective products.
The Group's strong commitment to quality, sustainability, continuous innovation process, and the talent of its people are at the heart of its success.
Headquartered in Avignon, France, Naturex has experienced steadily-increasing growth throughout the last 25 years. The Group employs 1,700 people worldwide and in 2017 had revenue of €404.9 million.
The Group is listed on Euronext Paris, Compartment B - Index: Euronext Next 150, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa - Ticker: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY